Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
eFFECTOR Therapeutics (EFTR) Stock Price & Analysis
260 Followers
EFTR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $20.51
Previous Close$0.06
Volume17.29K
Average Volume (3M)628.27K
Market Cap
$258.74K
Enterprise Value-$24.89M
Total Cash (Recent Filing)$25.38M
Total Debt (Recent Filing)$232.00K
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Aug 06, 2024EPS Estimate
-$2.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.31
Shares Outstanding4,704,409
10 Day Avg. Volume89,124
30 Day Avg. Volume628,267
Standard Deviation0.29
R-Squared0.02
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)6.66
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.92
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.99
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
eFFECTOR Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EFTR FAQ
What was eFFECTOR Therapeutics’s price range in the past 12 months?
eFFECTOR Therapeutics lowest stock price was $0.03 and its highest was $20.51 in the past 12 months.
What is eFFECTOR Therapeutics’s market cap?
Currently, no data Available
When is eFFECTOR Therapeutics’s upcoming earnings report date?
eFFECTOR Therapeutics’s upcoming earnings report date is Aug 06, 2024 which is in 15 days.
How were eFFECTOR Therapeutics’s earnings last quarter?
eFFECTOR Therapeutics released its earnings results on May 09, 2024. The company reported -$2.16 earnings per share for the quarter, beating the consensus estimate of -$2.165 by $0.005.
Is eFFECTOR Therapeutics overvalued?
According to Wall Street analysts eFFECTOR Therapeutics’s price is currently Overvalued.
Does eFFECTOR Therapeutics pay dividends?
eFFECTOR Therapeutics does not currently pay dividends.
What is eFFECTOR Therapeutics’s EPS estimate?
eFFECTOR Therapeutics’s EPS estimate is -$2.02.
How many shares outstanding does eFFECTOR Therapeutics have?
eFFECTOR Therapeutics has 4,704,409 shares outstanding.
What happened to eFFECTOR Therapeutics’s price movement after its last earnings report?
eFFECTOR Therapeutics reported an EPS of -$2.16 in its last earnings report, beating expectations of -$2.165. Following the earnings report the stock price went down -5.14%.
Which hedge fund is a major shareholder of eFFECTOR Therapeutics?
Among the largest hedge funds holding eFFECTOR Therapeutics’s share is Blackstone Inc.. It holds eFFECTOR Therapeutics’s shares valued at 753K.
---
eFFECTOR Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
EFTR Sentiment 85%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 44.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.1%
Last 30 Days ▼ 16.3%
Last 30 Days ▼ 16.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
23.73%
Trailing 12-Months
Company Description
eFFECTOR Therapeutics
Locust Walk Acquisition Corp is a blank check company.
---
EFTR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
ACADIA Pharmaceuticals
―
Akebia Therapeutics
―
Arvinas Holding Company
―
Crispr Therapeutics AG
―
Best Analysts Covering EFTR
1 Year
1 Year Success Rate
4/20 ratings generated profit
1 Year Average Return
-59.71%
reiterated a buy rating 6 months ago
Copying Mara Goldstein's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -59.71% per trade.
---